Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor α and hepatocyte growth factor in hepato-carcinogenesis
✍ Scribed by Snorri S. Thorgeirsson; Eric Santoni-Rugiu
- Book ID
- 119538868
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 124 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0378-4274
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Transforming growth factor (TGF)‐β1, whose gene is located on mouse chromosome 7, has been proposed to be involved in skin carcinogenesis. In the study presented here, we demonstrated that single topical treatments with different types of tumor promoters, i.e., the protein kinase C acti
After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.
Hepatocyte growth factor, a potent hepatocyte mitogen in vitro, appears to trigger hepatocyte regeneration after partial hepatectomy and after acute liver cell netcrosis. Transforming growth factor-a and transforming growth factor+, may also be involved in the control of liver regeneration. In this